CLINICAL_TRIALS
trial_result
· 2018-01-31
Clinical Trial Update: Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients [Phase 4]
Summary
Phase 4 trial updating outcomes for switching from omalizumab to mepolizumab in adults with severe eosinophilic asthma, results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2018-01-31